Late thrombotic events after bioresorbable scaffold implantation: A systematic review andmeta-analysis of randomized clinical trials
European Heart Journal , Volume 38 - Issue 33 p. 2559- 2564
Aims To compare the long-term safety and efficacy of bioresorbable vascular scaffold (BVS) with everolimus-eluting stent (EES) after percutaneous coronary interventions. Methods and results A systematic review and meta-analysis of randomized clinical trials comparing clinical outcomes of patients treated with BVS and EES with at least 24 months follow-up was performed. Adjusted random-effect model by the Knapp- Hartung method was used to compute odds ratios (OR) and 95% confidence intervals (CI). The primary safety outcome of interest was the risk of definite/probable device thrombosis (DT). The primary efficacy outcome of interest was the risk of target lesion failure (TLF). Five randomized clinical trials (n= 1730) were included. Patients treated with Absorb BVS had a higher risk of definite/probable DT compared with patients treated with EES (OR 2.93, 95%CI 1.37-6.26, P= 0.01). Very late DT (VLDT) occurred in 13 patients [12/996 (1.4%, 95%CI: 0.08-2.5) Absorb BVS vs. 1/701 (0.5%, 95%CI: 0.2-1.6) EES; OR 3.04; 95%CI 1.2-7.68, P = 0.03], 92% of the VLDT in the BVS group occurred in the absence of dual antiplatelet therapy (DAPT). Patients treated with Absorb BVS had a trend towards higher risk of TLF (OR 1.48, 95%CI 0.90-2.42, P= 0.09), driven by a higher risk of target vessel myocardial infarction and ischaemia-driven target lesion revascularization. No difference was found in the risk of cardiac death. Conclusion Compared with EES, the use of Absorb BVS was associated with a higher rate of DT and a trend towards higher risk of TLF. VLDT occurred in 1.4% of the patients, the majority of these events occurred in the absence of DAPT.
|Meta-analysis, Randomized trial, Scaffold, Thrombosis|
|European Heart Journal|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Collet, C, Asano, T, Miyazaki, Y, Tenekecioglu, E, Katagiri, Y, Sotomi, Y, … Serruys, P.W.J.C. (2017). Late thrombotic events after bioresorbable scaffold implantation: A systematic review andmeta-analysis of randomized clinical trials. European Heart Journal, 38(33), 2559–2564. doi:10.1093/eurheartj/ehx155